Search
Displaying 341–350 of 714 for “retinal diseases”
-
Vision Science Explained Through Animated Videos
This educational series aims to educate and inform viewers by simplifying science – helping people understand topics like blinding diseases, genetics, and clinical trials, without requiring advanced background knowledge.
-
Research News
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
-
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
Research NewsKnown as ultevursen, the USH2A RNA therapy was licensed from ProQR.
-
AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial
Research NewsThe trial is the first ever for a dual AAV gene therapy delivered to the retina.
-
Join the Foundation Fighting Blindness for our new program, Vision Connection, an enriching and supportive gathering for the blind and low vision community.
-
Research News
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
New Report: Vitamin A Supplementation Provides No Vision Benefit to RP Patients
Research NewsThe report also concludes that vitamin E supplementation accelerates vision loss for RP patients
-
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
Research NewsThe company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
SparingVision Recruiting for Clinical Trial of Cone-Preserving Gene Therapy for RP
Research NewsFirst cohort of patients has been dosed in Phase ½ clinical trial taking place in Pittsburgh and Paris
-
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
Research NewsKnown as The Lighthouse Study, the Phase ½ trial is expected to begin in mid-2023
.png)
